Ozempic tablets are now available; investigational ALS treatment gains FDA Fast Track status; positive results for aficamten ...
HealthDay News — As an investigation continues into a hantavirus outbreak that killed three passengers and sickened five on an ocean liner, the World Health Organization (WHO) says the odds of broader ...
A major amendment has prompted the FDA to extend its review of subcutaneous lecanemab as a starting dose for early Alzheimer disease.
Relative vaccine efficacy was 26.6 percent, which met the criteria for noninferiority, superiority, higher-level superiority.
Based on the current evidence, there is no consistent association between vaccines and serious or long-term health outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results